Cargando…

The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies

Latanoprostene bunod (LBN) is a topical ophthalmic therapeutic for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension (OHT). LBN is composed of latanoprost acid (LA) linked to a nitric oxide (NO)-donating moiety and is the first NO-releasing prost...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cavet, Megan E., DeCory, Heleen H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2018
Materias:	Volume 1: Glaucoma IOP, Neuroprotection and Devices
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963638/ https://www.ncbi.nlm.nih.gov/pubmed/28783422 http://dx.doi.org/10.1089/jop.2016.0188

Ejemplares similares

Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
por: Lin, Cheng-Wen, et al.
Publicado: (2018)

Critical evaluation of latanoprostene bunod in the treatment of glaucoma
por: Garcia, Giancarlo A, et al.
Publicado: (2016)

Evaluation of the Effect of Latanoprostene Bunod Ophthalmic Solution, 0.024% in Lowering Intraocular Pressure over 24 h in Healthy Japanese Subjects
por: Araie, Makoto, et al.
Publicado: (2015)

Use of Latanoprostene Bunod as Adjunctive Glaucoma Therapy in Refractory Glaucoma
por: Zhou, Benjamin, et al.
Publicado: (2022)

The Ability of Nitric Oxide to Lower Intraocular Pressure Is Dependent on Guanylyl Cyclase
por: Muenster, Stefan, et al.
Publicado: (2017)

Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma
por: Wang, Yulong, et al.
Publicado: (2020)

Proposed Mechanism of Long-Term Intraocular Pressure Lowering With the Bimatoprost Implant
por: Stamer, W. Daniel, et al.
Publicado: (2023)

Efficacy of selective laser trabeculoplasty on lowering intraocular pressure fluctuations and nocturnal peak intraocular pressure in treated primary open-angle glaucoma patients
por: Pillunat, Karin R., et al.
Publicado: (2022)

Harnessing the Endocannabinoid 2-Arachidonoylglycerol to Lower Intraocular Pressure in a Murine Model
por: Miller, Sally, et al.
Publicado: (2016)

Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
por: Hoy, Sheridan M.
Publicado: (2018)

Latanoprostene Bunod 0.024% in the Treatment of Open-Angle Glaucoma and Ocular Hypertension: A Meta-Analysis
por: Lo, Tzu-Chen, et al.
Publicado: (2022)

Short-Term Changes in the Photopic Negative Response Following Intraocular Pressure Lowering in Glaucoma
por: Tang, Jessica, et al.
Publicado: (2020)

Long-term follow-up of intraocular pressure and pressure-lowering medication in patients following Excimer laser trabeculotomy
por: Deubel, C., et al.
Publicado: (2020)

Cataract Surgery to Lower Intraocular Pressure
por: Berdahl, John P.
Publicado: (2009)

Morphologic Changes in the Lamina Cribrosa Upon Intraocular Pressure Lowering in Patients With Normal Tension Glaucoma
por: Kim, Jeong-Ah, et al.
Publicado: (2022)

Younger age is associated with greater early neurocognitive decline postcardiopulmonary bypass
por: Anderson, Kelsey, et al.
Publicado: (2020)

Correction to: Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
por: Hoy, Sheridan M.
Publicado: (2018)

Latanoprostene bunod ophthalmic solution 0.024% in the treatment of open-angle glaucoma: design, development, and place in therapy
por: Addis, Victoria M, et al.
Publicado: (2018)

Intraocular pressure fluctuation during resistance exercise
por: Vaghefi, Ehsan, et al.
Publicado: (2021)

Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open‐angle glaucoma and ocular hypertension
por: Fingeret, Murray, et al.
Publicado: (2019)

Stanniocalcin-1 Is an Ocular Hypotensive Agent and a Downstream Effector Molecule That Is Necessary for the Intraocular Pressure–Lowering Effects of Latanoprost
por: Roddy, Gavin W., et al.
Publicado: (2017)

Differences in Factors Associated With Glaucoma Progression With Lower Normal Intraocular Pressure in Superior and Inferior Halves of the Optic Nerve Head
por: Asaoka, Ryo, et al.
Publicado: (2023)

High Blood Pressure and Intraocular Pressure: A Mendelian Randomization Study
por: Plotnikov, Denis, et al.
Publicado: (2022)

Lamina Cribrosa Capillaries Straighten as Intraocular Pressure Increases
por: Brazile, Bryn L., et al.
Publicado: (2020)

Δ(9)-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure
por: Miller, Sally, et al.
Publicado: (2018)

The Effect of Change in Intraocular Pressure on Choroidal Structure in Glaucomatous Eyes
por: Zhang, Xuemin, et al.
Publicado: (2017)

Adrenal and Glucocorticoid Effects on the Circadian Rhythm of Murine Intraocular Pressure
por: Tsuchiya, Shunsuke, et al.
Publicado: (2018)

Retrospective Chart Review on Real-World Use of Latanoprostene Bunod 0.024% in Treatment-Naïve Patients with Open-Angle Glaucoma
por: Okeke, Constance O., et al.
Publicado: (2020)

Evidence for a GPR18 Role in Diurnal Regulation of Intraocular Pressure
por: Miller, Sally, et al.
Publicado: (2016)

Intraocular Pressure Elevation Compromises Retinal Ganglion Cell Light Adaptation
por: Tao, Xiaofeng, et al.
Publicado: (2020)

Paraventricular Hypothalamic Nucleus Upregulates Intraocular Pressure Via Glutamatergic Neurons
por: Ma, Lin, et al.
Publicado: (2023)

The Role of Wnt/β-Catenin Signaling and K-Cadherin in the Regulation of Intraocular Pressure
por: Webber, Hannah C., et al.
Publicado: (2018)

Transient Intraocular Pressure Fluctuations: Source, Magnitude, Frequency, and Associated Mechanical Energy
por: Turner, Daniel C., et al.
Publicado: (2019)

Effect of αvβ3 Integrin Expression and Activity on Intraocular Pressure
por: Faralli, Jennifer A., et al.
Publicado: (2019)

Response of the Trilaminar Retinal Vessel Network to Intraocular Pressure Elevation in Rat Eyes
por: Zhao, Da, et al.
Publicado: (2020)

Immediate Impact of Acute Elevation of Intraocular Pressure on Cortical Visual Motion Processing
por: Yuan, Nini, et al.
Publicado: (2020)

Posture-Related Changes of Intraocular Pressure in Patients With Acute Primary Angle Closure
por: Hsia, Yun, et al.
Publicado: (2021)

Potential Mechanisms of Intraocular Pressure Reduction by Micropulse Transscleral Cyclophotocoagulation in Rabbit Eyes
por: Nemoto, Hotaka, et al.
Publicado: (2022)

Role of excessive weight in intraocular pressure: a systematic review and meta-analysis
por: Waspodo, Noro, et al.
Publicado: (2023)

Risk Factors Associated with Structural Progression in Normal-Tension Glaucoma: Intraocular Pressure, Systemic Blood Pressure, and Myopia
por: Lee, Kwanghyun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3kk3jn57f2487se7ifvl5052v9